Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 2
2006 5
2007 2
2008 2
2009 1
2010 2
2011 5
2012 7
2013 4
2014 4
2015 4
2016 5
2017 6
2018 5
2019 4
2020 8
2021 5
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
HIV-1 non-B subtypes in Italy: a growing trend.
Ciccozzi M, Santoro MM, Giovanetti M, Andrissi L, Bertoli A, Ciotti M. Ciccozzi M, et al. Among authors: bertoli a. New Microbiol. 2012 Oct;35(4):377-86. Epub 2012 Oct 1. New Microbiol. 2012. PMID: 23109005 Free article. Review.
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
Piermatteo L, D'Anna S, Bertoli A, Bellocchi M, Carioti L, Fabeni L, Alkhatib M, Frazia S, Lichtner M, Mastroianni C, Sanctis G, Marignani M, Pasquazzi C, Iapadre N, Parruti G, Cappiello G, Vecchiet J, Malagnino V, Grelli S, Ceccherini-Silbertein F, Andreoni M, Sarmati L, Svicher V, Salpini R. Piermatteo L, et al. Among authors: bertoli a. Emerg Microbes Infect. 2023 Dec;12(1):2219347. doi: 10.1080/22221751.2023.2219347. Emerg Microbes Infect. 2023. PMID: 37288750 Free PMC article.
Clinical cut-offs in the interpretation of phenotypic resistance.
Perno CF, Bertoli A. Perno CF, et al. Among authors: bertoli a. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 7. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 7. PMID: 21249778 Free Books & Documents. Review.
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches.
Vergni D, Santoni D, Bouba Y, Lemme S, Fabeni L, Carioti L, Bertoli A, Gennari W, Forbici F, Perno CF, Gagliardini R, Ceccherini-Silberstein F, Santoro MM; HIV drug-resistance group. Vergni D, et al. Among authors: bertoli a. Infect Genet Evol. 2022 Jul;101:105294. doi: 10.1016/j.meegid.2022.105294. Epub 2022 May 2. Infect Genet Evol. 2022. PMID: 35513162 Free article.
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.
Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer AE, Lara M, Pardo MR, Zoller H, Degasperi E, Peiffer KH, Sighinolfi L, Téllez F, Graf C, Ghisetti V, Schreiber J, Fernández-Fuertes E, Boglione L, Muñoz-Medina L, Stauber R, Gennari W, Figueruela B, Santos J, Lampertico P, Zeuzem S, Ceccherini-Silberstein F, García F, Sarrazin C; HCV Virology Italian Resistance Network (VIRONET-C) collaborators; Spanish GEHEP-004 Collaborators; Members of the German HCV resistance study group. Dietz J, et al. J Hepatol. 2021 Apr;74(4):801-810. doi: 10.1016/j.jhep.2020.11.017. Epub 2020 Nov 19. J Hepatol. 2021. PMID: 33220331
Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients.
Cerva C, Salpini R, Alkhatib M, Malagnino V, Piermatteo L, Battisti A, Bertoli A, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Ferrari L, Laura C, Teti E, Cantonetti M, Arcese W, Ceccherini-Silberstein F, Perno CF, Andreoni M, Svicher V, Sarmati L. Cerva C, et al. Among authors: bertoli a. Biomedicines. 2022 Feb 14;10(2):443. doi: 10.3390/biomedicines10020443. Biomedicines. 2022. PMID: 35203653 Free PMC article.
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice.
Armenia D, Forbici F, Bertoli A, Berno G, Malagnino V, Gagliardini R, Borghi V, Gennari W, Cicalini S, Buonomini A, Teti E, Lanini S, Latini A, Sarmati L, Mussini C, Andreoni M, Antinori A, Perno CF, Ceccherini-Silberstein F, Santoro MM. Armenia D, et al. Among authors: bertoli a. J Glob Antimicrob Resist. 2022 Sep;30:326-334. doi: 10.1016/j.jgar.2022.06.027. Epub 2022 Jul 3. J Glob Antimicrob Resist. 2022. PMID: 35793776 Free article.
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment.
Piermatteo L, Scutari R, Chirichiello R, Alkhatib M, Malagnino V, Bertoli A, Iapadre N, Ciotti M, Sarmati L, Andreoni M, Ceccherini-Silberstein F, Salpini R, Svicher V. Piermatteo L, et al. Among authors: bertoli a. Methods. 2022 May;201:74-81. doi: 10.1016/j.ymeth.2021.05.011. Epub 2021 May 14. Methods. 2022. PMID: 34000391 Free article.
Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations.
Costanza G, Paba P, Ciotti M, Ombres D, Di Carlo S, Marcuccilli F, Bertoli A, Di Traglia L, Mozzani M, Piredda L, Petrone V, Fanelli M, Paganelli C, Cortese B, Balestrieri E, Bernardini S, Andreoni M, Matteucci C, Minutolo A, Grelli S. Costanza G, et al. Among authors: bertoli a. Biomolecules. 2022 Jul 15;12(7):987. doi: 10.3390/biom12070987. Biomolecules. 2022. PMID: 35883543 Free PMC article.
82 results